'Drug candidate' diaporamas de présentation

Dosage Form Design Lecture 3 24/2/2019 Dr. Athmar Dhahir Habeeb

Dosage Form Design Lecture 3 24/2/2019 Dr. Athmar Dhahir Habeeb PhD in Industrial pharmacy and drug delivery athmar1978@uomustansiriyah.edu.iq athmar1978@yahoo.com a th mar.habeeb.12@ucl.ac.uk. Biologic Characterization.

412 views • 39 slides

Part I: Assessing Early Stage Candidate

Development and Approval of Drugs and Devices EPI260 Lecture 2: How to Assess an Early Stage Drug Candidate and Drug Development Lessons April 4, 2012 Richard Chin, M.D. Part I: Assessing Early Stage Candidate.

468 views • 35 slides

524 views • 31 slides

UBS 22 ND ANNUAL GLOBAL HEALTHCARE SERVICES CONFERENCE FEBRUARY 2012

UBS 22 ND ANNUAL GLOBAL HEALTHCARE SERVICES CONFERENCE FEBRUARY 2012. PREMIER global preclinical services provider. World-class preclinical service provider offering unparalleled expertise and expert scientific staff providing services from early discovery to IND filing and beyond

269 views • 17 slides

Overview

Development and Approval of Drugs and Devices EPI260 Lecture 12: Lessons from Drug Development June 3, 2010 Richard Chin, M.D. Overview. How regulations evolve Risks of drug development CAST FIAU University of Pennsylvania Vioxx Tysabri TeGenero. Regulations.

229 views • 10 slides

Discover the Idiopathic Pulmonary Fibrosis (IPF) Pipeline Exhibits Strong Pipeline With 95 Drug Candidates

The study analyzed that the IPF pipeline comprised of 97 therapeutic candidates, of which 15 are in Phase II stage of development. The lack of complete cure for IPF fuels the extensive research and development for the IPF therapeutic. Various drugs are being developed as novel and promising therapeutics for the treatment of IPF.

82 views • 6 slides

Prostatitis Therapeutics Pipeline Analysis by Stages, Drug Class, Company Profile

Prostatitis Therapeutics Segmental Analysis by Therapeutics, Diagnostics, Patient ,Drugs Policy & Regulatory Landscape

120 views • 6 slides

Progressive Supranuclear Palsy Therapeutics Pipeline to Develop More Drugs as Small Molecule

Progressive Supranuclear Palsy Pipeline: Report Provides a Comprehensive Understanding of the Pipeline Activities Covering All Drug Candidates Under Various Stages of Development.

115 views • 6 slides

Prostatitis Therapeutics Pipeline - Phase III Drug Candidate Is Expected to Commercialize in The Coming Years

Prostatitis Therapeutics Pipeline Analysis by Stages, Drug Class, Company Profile, Phase of Development, Clinical Trial, Preclinical Research & Discovery Stage Insights.

84 views • 6 slides

Prostatitis Therapeutics Pipeline Drug Profile, Top Industry Intelligence and Therapeutic Development

Prostatitis Therapeutics Pipeline Products Under Drug Profile Includes Product Description & Developmental Activities, Licensing and Collaboration Details .

82 views • 6 slides

The pharmaceutical R&D process

149 views • 6 slides